CN104984164A - Traditional Chinese medicine for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia and preparing method of traditional Chinese medicine - Google Patents
Traditional Chinese medicine for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia and preparing method of traditional Chinese medicine Download PDFInfo
- Publication number
- CN104984164A CN104984164A CN201510413255.5A CN201510413255A CN104984164A CN 104984164 A CN104984164 A CN 104984164A CN 201510413255 A CN201510413255 A CN 201510413255A CN 104984164 A CN104984164 A CN 104984164A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- mixed powder
- obtains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 title claims abstract description 22
- 208000031971 Yin Deficiency Diseases 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title abstract description 8
- 241000921449 Rhodobryum roseum Species 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
- 239000002245 particle Substances 0.000 claims description 40
- 239000011812 mixed powder Substances 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 32
- 239000000284 extract Substances 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 26
- 241000219095 Vitis Species 0.000 claims description 20
- 235000009392 Vitis Nutrition 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 241000209215 Eleusine Species 0.000 claims description 19
- 235000007351 Eleusine Nutrition 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 19
- 241000221427 Tremella mesenterica Species 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 230000001476 alcoholic effect Effects 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- 239000002105 nanoparticle Substances 0.000 claims description 10
- 238000005325 percolation Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 238000005262 decarbonization Methods 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000012982 microporous membrane Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008215 water for injection Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000012567 medical material Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 11
- 235000018645 Allium odorum Nutrition 0.000 abstract description 3
- 244000025670 Eleusine indica Species 0.000 abstract description 3
- 244000292697 Polygonum aviculare Species 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 241000561734 Celosia cristata Species 0.000 abstract description 2
- 235000014716 Eleusine indica Nutrition 0.000 abstract description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract description 2
- 235000014787 Vitis vinifera Nutrition 0.000 abstract description 2
- 240000006365 Vitis vinifera Species 0.000 abstract description 2
- 210000001520 comb Anatomy 0.000 abstract description 2
- 244000000383 Allium odorum Species 0.000 abstract 1
- 235000000832 Ayote Nutrition 0.000 abstract 1
- 241000167550 Centella Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 240000004244 Cucurbita moschata Species 0.000 abstract 1
- 235000009854 Cucurbita moschata Nutrition 0.000 abstract 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 240000001140 Mimosa pudica Species 0.000 abstract 1
- 235000016462 Mimosa pudica Nutrition 0.000 abstract 1
- 241000159443 Myrcia Species 0.000 abstract 1
- 241000107360 Vincetoxicum glaucescens Species 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 235000015136 pumpkin Nutrition 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 32
- 244000025254 Cannabis sativa Species 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 241000411851 herbal medicine Species 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 229910052742 iron Inorganic materials 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 208000007502 anemia Diseases 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 4
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 240000008654 Allium ramosum Species 0.000 description 2
- 244000066882 Allium wallichii Species 0.000 description 2
- 241000233788 Arecaceae Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 241001310717 Daphne genkwa Species 0.000 description 2
- 208000027219 Deficiency disease Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 240000000966 Allium tricoccum Species 0.000 description 1
- 235000006905 Allium tricoccum Nutrition 0.000 description 1
- 235000018640 Allium wallichii Nutrition 0.000 description 1
- 241001083548 Anemone Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 241000180579 Arca Species 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 241001435059 Artemisia argyi Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241001024902 Biophytum Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001504282 Bryaceae Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241001048935 Dendrobium chryseum Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000023329 Gun shot wound Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 244000018434 Hydrocotyle sibthorpioides Species 0.000 description 1
- 235000002788 Hydrocotyle sibthorpioides Nutrition 0.000 description 1
- 244000202566 Hydrocotyle vulgaris Species 0.000 description 1
- 235000015916 Hydrocotyle vulgaris Nutrition 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 244000308415 Justicia procumbens Species 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 241000196322 Marchantia Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001139947 Mida Species 0.000 description 1
- 241001490213 Milium Species 0.000 description 1
- 235000005052 Milium effusum Nutrition 0.000 description 1
- 241000195908 Mnium Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000117280 Naematelia aurantialba Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000208181 Pelargonium Species 0.000 description 1
- 244000270673 Pelargonium graveolens Species 0.000 description 1
- 235000017927 Pelargonium graveolens Nutrition 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 240000001619 Prunus glandulosa Species 0.000 description 1
- 235000018992 Prunus glandulosa Nutrition 0.000 description 1
- 235000013999 Prunus japonica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000304447 Sempervivum tectorum Species 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 235000008950 Sommerlauch Nutrition 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000221424 Tremellaceae Species 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- FWZTTZUKDVJDCM-CEJAUHOTSA-M disodium;(2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);hydroxide;trihydrate Chemical compound O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FWZTTZUKDVJDCM-CEJAUHOTSA-M 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical group [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 231100000567 intoxicating Toxicity 0.000 description 1
- 230000002673 intoxicating effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940082629 iron antianemic preparations Drugs 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- MVZXTUSAYBWAAM-UHFFFAOYSA-N iron;sulfuric acid Chemical compound [Fe].OS(O)(=O)=O MVZXTUSAYBWAAM-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940057531 saccharated iron oxide Drugs 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides traditional Chinese medicine for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia and a preparing method of the traditional Chinese medicine. The traditional Chinese medicine comprises the following raw medical materials including sensitive plant, centella, coix lacryma-jobi leaves, wild fragrant-flowered garlic, coriaceous knotweed rhizome, cockscomb, pumpkin, cynanchum glaucescens, eleusine indica, yellow fungus, goldfussia psilostachys, myrcia, grapevine stems and leaves and rhodobryum roseum. The traditional Chinese medicine has the beneficial effects that the traditional Chinese medicine is used for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia; the curative effect is exact; the side effects are few; the use is convenient. The preparing method has the advantages that the process is simple, and the industrial production is easy.
Description
Technical field
The present invention relates to pharmaceutical technology, particularly relate to a kind of Chinese medicine and preparation method for the treatment of liver-kidney yin deficiency iron Deficiency Anemia.
Background technology
Iron deficiency anemia (iron deficiency ancemia) is the commonly encountered diseases of children's, mainly occurs in the infant in June to 3 year old.There is the features such as the low color of minicell, serum levels of iron and transferrin saturation reduce, iron in treatment is respond well.After liberation, various food deficiency disease all obviously reduces, but iron deficiency anemia is still the food deficiency disease of common threat child health.According to national 16 provinces and cities in 1981 to the investigation of 8435 29 days to 7 years old children's, hemoglobin in the prevalence of the nutritional anemia of below 110g/L up to 36.31%; June to 6 year old children's 9027, prevalence is 43.03%.Thus this is problem anxious to be resolved in child health care work.
Chalybeate is the specific drug for the treatment of iron deficiency anemia, and its kind is a lot, is generally most economical, convenient and effective method with oral inorganic salt.Ferrous iron absorption easier than ferric iron, therefore adopt, conventional has ferrous lactate, and iron-holder is 20%, and this amount can reach the maximum of absorption, and exceed this amount and absorb decline, increase the stimulation to gastric mucosa on the contrary, dosage is excessive produces intoxicating phenomenon. moreTake medicine best between two meal, both reduced the stimulation to gastric mucosa, and be beneficial to absorption again.Should avoid taking with great deal of milk simultaneously, because milk is phosphorous higher, the absorption of ferrum can be affected.
For can not tolerate Oral Iron Preparations, diarrhoea is serious and sick child that anemia is heavier, needs consideration chalybeate to inject.Conventional rail injection agent has: iron dextran, every ml iron content 50mg, intramuscular injection; Saccharated iron oxide, every ml iron content 20mg, intravenous injection.Intramuscular injection chalybeate local can produce pain and urticaria, is also shown in heating, arthralgia, headache or regional glandular enlargement etc.Also can there is angiitis obliterans in intravenous injection chalybeate.The response to treatment of injection chalybeate unlike soon oral, therefore must be cautious use of.
Iron in treatment generally must continue to be applied to erythrocyte and hemoglobin and reach after normal level at least 6 ~ 8 weeks.Because of iron deficiency anemia, not only hemoglobin reduction, storage iron also exhausts.Due to the continuous growth promoter of children's, blood volume constantly expands, and can not meet the needs of ferrum in diet, and therapeutic purposes only should not correct iron deficiency anemia, and should store enough ferrum, for future use.Vitamin B12, folic acid or extractum hepatis are invalid for treatment iron deficiency anemia, can not abuse.
Summary of the invention
Technical problem to be solved by this invention is, provides a kind of Chinese medicine and preparation method for the treatment of liver-kidney yin deficiency iron Deficiency Anemia, and this Chinese medicine is to treatment liver-kidney yin deficiency iron Deficiency Anemia, and determined curative effect, side effect is little, easy to use.
In order to solve the problems of the technologies described above, the invention provides a kind of Chinese medicine for the treatment of liver-kidney yin deficiency iron Deficiency Anemia, wherein, comprise following raw medicinal material: Herba Mimosae Pudicae, Herba Centellae, Folium Coicis, Herba Allii bulleyani, Rhizoma Polygoni coriacei, Flos Celosiae Cristatae, Caulis Cucurbitae, Rhizoma Cynanchi Stauntonii, Herba Eleusines Indicae, Tremella mesenterica Retz ex Fr., Herba Goldffussiae Psilostachydis, Herba Pelargonii Graveolentis, Caulis et Folium vitis viniferae and Rhodobryum roseum Limpr..
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can be preferably: Herba Mimosae Pudicae 5 ~ 15 parts, Herba Centellae 10 ~ 20 parts, Folium Coicis 15 ~ 25 parts, Herba Allii bulleyani 10 ~ 20 parts, Rhizoma Polygoni coriacei 25 ~ 35 parts, Flos Celosiae Cristatae 22 ~ 32 parts, Caulis Cucurbitae 30 ~ 40 parts, Rhizoma Cynanchi Stauntonii 15 ~ 25 parts, Herba Eleusines Indicae 26 ~ 36 parts, Tremella mesenterica Retz ex Fr. 20 ~ 30 parts, Herba Goldffussiae Psilostachydis 8 ~ 18 parts, Herba Pelargonii Graveolentis 20 ~ 30 parts, Caulis et Folium vitis viniferae 16 ~ 26 parts and Rhodobryum roseum Limpr. 14 ~ 24 parts.
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can also be preferably: Herba Mimosae Pudicae 6 ~ 11 parts, Herba Centellae 15 ~ 20 parts, Folium Coicis 17 ~ 22 parts, Herba Allii bulleyani 12 ~ 17 parts, Rhizoma Polygoni coriacei 30 ~ 35 parts, Flos Celosiae Cristatae 24 ~ 29 parts, Caulis Cucurbitae 32 ~ 37 parts, Rhizoma Cynanchi Stauntonii 17 ~ 22 parts, Herba Eleusines Indicae 28 ~ 33 parts, Tremella mesenterica Retz ex Fr. 25 ~ 30 parts, Herba Goldffussiae Psilostachydis 11 ~ 16 parts, Herba Pelargonii Graveolentis 25 ~ 30 parts, Caulis et Folium vitis viniferae 19 ~ 24 parts and Rhodobryum roseum Limpr. 17 ~ 22 parts.
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can be preferably again: Herba Mimosae Pudicae 10 parts, Herba Centellae 16 parts, Folium Coicis 21 parts, Herba Allii bulleyani 13 parts, Rhizoma Polygoni coriacei 34 parts, Flos Celosiae Cristatae 25 parts, Caulis Cucurbitae 36 parts, Rhizoma Cynanchi Stauntonii 18 parts, Herba Eleusines Indicae 32 parts, Tremella mesenterica Retz ex Fr. 26 parts, Herba Goldffussiae Psilostachydis 15 parts, Herba Pelargonii Graveolentis 26 parts, Caulis et Folium vitis viniferae 20 parts and Rhodobryum roseum Limpr. 18 parts.
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can be preferably again: Herba Mimosae Pudicae 8 parts, Herba Centellae 18 parts, Folium Coicis 19 parts, Herba Allii bulleyani 15 parts, Rhizoma Polygoni coriacei 30 parts, Flos Celosiae Cristatae 28 parts, Caulis Cucurbitae 33 parts, Rhizoma Cynanchi Stauntonii 21 parts, Herba Eleusines Indicae 30 parts, Tremella mesenterica Retz ex Fr. 28 parts, Herba Goldffussiae Psilostachydis 12 parts, Herba Pelargonii Graveolentis 29 parts, Caulis et Folium vitis viniferae 22 parts and Rhodobryum roseum Limpr. 20 parts.
Wherein, when the dosage form of described Chinese medicine is tablet, its preparation method comprises the following steps:
The first step, is mixed in proportion each for described Chinese medicine raw medicinal material, and adding relative to the determining alcohol of mixture quality 2 ~ 4 times is the ethanol of 85 ~ 95%, reflux 1 ~ 3 hour, extracts, and filters acquisition first extracting solution; It is the ethanol of 85 ~ 95% that the medicinal residues that filtration obtains add relative to the determining alcohol of described medicinal residues quality 1 ~ 2 times again, reflux 1 ~ 3 hour, extracts, and filters acquisition second extracting solution; First extracting solution and the second extracting solution are merged, concentrating under reduced pressure removing alcohol solvent, dry, obtain and get dry extract;
Second step, is placed on the dry cream that the first step obtains in super micron mill and pulverizes 1 ~ 2 hour, pulverize, sieve, obtain 300 order ~ 400 object micropowders;
3rd step, by the micropowders that second step obtains, add relative to the microcrystalline Cellulose of its quality 0.1 ~ 0.3 times, 0.05 ~ 0.15 times of lactose, the starch of 0.1 ~ 0.3 times, sieve, mix homogeneously, granulate, drying, adds relative to micropowders quality 0.005 ~ 0.05 times of magnesium stearate, granulate, tabletting, makes.
Wherein, when the dosage form of described Chinese medicine is injectable powder, its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 0.1 ~ 10 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 3 ~ 5 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85% ~ 95%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 24 ~ 36 hours under the condition of 5 DEG C ~ 10 DEG C, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 40 ~ 60 minutes at this, the micron particles of acquisition 0.1 ~ 10 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets mixed powder 10g ~ 20g that second step obtains, adds propylene glycol 30g ~ 50g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1g ~ 1.5g needle-use activated carbon, fully stir 30 ~ 50 minutes; Decarbonization filtering; With 0.22 ~ 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
Beneficial effect of the present invention: Chinese medicine of the present invention is to treating liver-kidney yin deficiency iron Deficiency Anemia, determined curative effect, and side effect is little, easy to use; It is simple that preparation method has technique, is easy to industrial advantage.
Detailed description of the invention
Of the present inventionly provide a kind of Chinese medicine for the treatment of liver-kidney yin deficiency iron Deficiency Anemia, wherein, comprise following raw medicinal material: Herba Mimosae Pudicae, Herba Centellae, Folium Coicis, Herba Allii bulleyani, Rhizoma Polygoni coriacei, Flos Celosiae Cristatae, Caulis Cucurbitae, Rhizoma Cynanchi Stauntonii, Herba Eleusines Indicae, Tremella mesenterica Retz ex Fr., Herba Goldffussiae Psilostachydis, Herba Pelargonii Graveolentis, Caulis et Folium vitis viniferae and Rhodobryum roseum Limpr..
In described Chinese medicine, the pharmacology of each raw medicinal material is as follows:
Herba Mimosae Pudicae: [another name] know shy grass, coy grass, drink exhale grass, be afraid of ugly grass, Herba cassiae occidentalis, henpecked grass, Biophytum nanum H. Chuang sp. Nov. Ined.-B. Sensitivum auct. Non (L.) DC..[source] medical material Ji Yuan: be the herb of leguminous plant Herba Mimosae Pudicae.[nature and flavor] are bitter; Puckery; Micro-hardship; Be slightly cold; Mild toxicity.[return through] heart; Liver; Stomach; Large intestine channel.[function cures mainly] removing pathogenic heat from blood and toxic substance from the body; Clearing away heat-damp and promoting diuresis; Tranquillizing and allaying excitement.Main flu; Infantile hyperpyrexia; Bronchitis; Hepatitis; Intestinal is scorching; Conjunctivitis; Urinary system calculus; Edema; Impairment caused by overstrain hemoptysis; Epistaxis; Hematuria; Neurasthenia; Insomnia; Sore swollen toxin; Herpes zoster; Traumatic injury.[extracts] " China's book on Chinese herbal medicine "
Herba Centellae: [another name] Herba Glechomae, marchantia grass, Herba Calthae Membranaceae, Gotu Kola, certain herbaceous plants with big flowers Penglai, chipping bowl, Herba sambuci chinensis, Chinese bush cherry grass, large Herba Calthae Membranaceae, TUXIXIN, collapse jorum, Gotu Kola, the Congo dragon, Herba Centellae taro grass, something that gives the game away mark, bud Dendrobium denneanum Kerr., careless as one wishes, Carnis Arca inflata shell is careless, determine containing shell grass, bowl of begging for food, old jackal bowl, flood money, Hydrocotyle sibthorpioides lam.Var.Batvachium (Hand.-Mazz.) et shan. grass, Hydrocotyle vulgaris L., old duck, bowl is broken in ferrum oil lamp, half of bowl, Herba speranskiae tuberculatae, jumping, Thunder God bowl, Herba Asari, Herba lysimachiae capillipedis.[source] medical material Ji Yuan: be the herb of samphire Herba Centellae.[nature and flavor] bitter in the mouth; Pungent; Cold in nature.[return through] returns lung; Spleen; Kidney; Urinary bladder channel.[function cures mainly] clearing away heat-damp and promoting diuresis; Promoting blood circulation and hemostasis; Removing toxic substances and promoting subsidence of swelling.Main heating; Cough with asthma; Laryngopharynx swelling and pain; Intestinal for for; Dysentery; Jaundice due to damp-heat; Edema; Stranguria; Hematuria; Epistaxis; Dysmenorrhea; Metrorrhagia; Erysipelas; Scrofula; Parent's pyogenic infections from tumour or sore; Herpes zoster; Treating swelling and pain by traumatic injury; Traumatic hemorrhage; Snake bite and insect sting.[extracts] " China's book on Chinese herbal medicine "
Folium Coicis: [source] medical material Ji Yuan: the leaf of grass Semen Coicis.[function cures mainly] warming spleen and stomach for dispelling cold; Benefiting vital QI and blood.Main cold syndrome of the stomach pain; Deficient qi and blood.[extracts] " China's book on Chinese herbal medicine "
Herba Allii bulleyani: [another name] Sempervivum tectorum, Radix Ophiopogonis, wild leek, wild Radix Ophiopogonis, book band are careless, black spends wild fragrant-flowered garlic, black colored fragrant-flowered garlic.[source] medical material Ji Yuan: be the herb of liliaceous plant Allium wallichii.Latin plant animal mineral name: Allium wallichii Kunth [A.tchongchanense Levl.; A.bulleyanrmDiels].[nature and flavor] acrid in the mouth; Sweet; Property is put down.[return through] liver; Spleen channel.[function cures mainly] promoting blood circulation to remove blood stasis; Dispelling wind for relieving itching.Main traumatic injury; Gunshot wound; Urticaria; Psoriasis; Dermatitis rhus.[extracts] " China's book on Chinese herbal medicine "
Rhizoma Polygoni coriacei: [another name] chicken feet king, Rhizoma Bistortae, hornet seven, Rhizoma Polygoni Paleachi.[source] medical material Ji Yuan: be the rhizome of polygonaceae plant leather leaf knotweed.Latin plant animal mineral name: Polygonum coriaceumSam.[nature and flavor] are bitter; Cold in nature.[function cures mainly] heat-clearing and toxic substances removing.Main hygropyretic dysentery; Diarrhoea; Carbuncle; Hemorrhoid; Gingival swelling and pain; Erosion of the oral mucosa; Burn; Venom.[extracts] " China's book on Chinese herbal medicine "
Flos Celosiae Cristatae: [another name] chicken hair worn in a bun or coil flower, cock flower, chicken angle rifle, cockscomb head, Os Gallus domesticus flower, an old person having a young heart' a person old in age but young in spirit.[source] medical material Ji Yuan: be the inflorescence of amaranthaceous plant Flos Celosiae Cristatae.[nature and flavor] are sweet; Cool; Nontoxic.[return through] liver; Kidney channel.[function cures mainly] removing heat from blood; Hemostasis.Main anal fistula hematochezia; Red white dysentery; Spit blood; Hemoptysis; Stranguria with blood; Women's metrorrhagia; Leucorrhea with red and white discharge.[extracts] " China's book on Chinese herbal medicine "
Caulis Cucurbitae: [source] medical material Ji Yuan: be the stem of cucurbitaceous plant Fructus Cucurbitae moschatae.[nature and flavor] sweet in the mouth; Bitter; Cold nature.[return through] enters liver; Stomach; Lung meridian.[function cures mainly] lung heat clearing; Suppressing the hyperactive liver; Stomach function regulating; Dredging collateral.Main pulmonary tuberculosis low grade fever; Stomachache due to hyperactive liver-QI attacking the stomach; Menoxenia; Acute catarrhal conjunctivitis swelling pain; Burn due to hot liquid or fire.[extracts] " China's book on Chinese herbal medicine "
Rhizoma Cynanchi Stauntonii: [another name] Shi Lan, medicine of coughing, rhizoma et radix cynanchi stauntoni, Radix Homonoiae Ripariae, large crane wooden dipper, water willow, leaves of Daphne genkwa Rhizoma Cynanchi Stauntonii, small stream wooden dipper thick soup, the knot grass that disappears, crow obstruct son, sweet Rhizoma Cynanchi Stauntonii, fry Rhizoma Cynanchi Stauntonii, goose pipe Rhizoma Cynanchi Stauntonii.[source] medical material Ji Yuan: be the root and rhizome of dicotyledon medicine asclepiadaceae plant rhizoma et radix cynanchi stauntoni or leaves of Daphne genkwa Rhizoma Cynanchi Stauntonii.[nature and flavor] Xin Gan; Tepor; Nontoxic.[return through] lung meridian.[function cures mainly] eliminating the pathogens from the lung sending down the abnormal ascending QI; Lower expectorant antitussive.Main smelting lung qi stops up the cough with copious phlegm of reality; Dyspnea due to adverseness of QI; Gastralgia; Youngster's infantile malnutrition; Traumatic injury.[extracts] " China's book on Chinese herbal medicine "
Herba Eleusines Indicae: [another name] a thousand pieces of gold grass, 1,000 to step on, young grass of being unworthy of the honour, thousand people pull out, Shen grass, Niu Duncao, duck foot grass, foxtail millet are young more, pheasant pawl, chestnut cattle eggplant grass, yard grass, flat grass, water bull grass, careless, the very heavy grass of Cryllus testaceus wallker, chi basin grass, Pathways Grass, millet grass, flaccid anemone, wild duck foot dish, old donkey is careless, hundred nights are careless.[source] medical material Ji Yuan: be root or the herb of grass Herba Eleusines Indicae.[nature and flavor] are sweet; Light; Cool.[function cures mainly] clearing away heat-damp and promoting diuresis; Removing pathogenic heat from blood and toxic substance from the body.Main Sunstroke heating; Infantile convulsion; Encephalitis b; Epidemic encephalitis; Jaundice; Stranguria; Dysuria; Dysentery; Have blood in stool; Skin infection swells and ache; Traumatic injury.[extracts] " China's book on Chinese herbal medicine "
Tremella mesenterica Retz ex Fr.: [another name] golden Auricularia, Tremella mesenterica, yellow ear.[source] medical material Ji Yuan: be the sporophore of Tremellaceae plant Tremella aurantialba Bandoni et Zang.[nature and flavor] are sweet; Flat.[return through] lung meridian.[function cures mainly] nourishing YIN and moistening the lung; Promoting the production of body fluid to quench thirst.Main cough due to consumptive disease; Sputum mixed with blood; Tianjin is few thirsty; Osteopyrexia and fever; Night sweat.[extracts] " China's book on Chinese herbal medicine "
Herba Goldffussiae Psilostachydis: [another name] Championella maclurei (Merr) c. Y. Wu et H. S. L..[source] medical material Ji Yuan: be stem, the leaf of acanthaceous plant thin fringe gold foot grass.[nature and flavor] taste is micro-pungent; Bitter cool.[function cures mainly] heat-clearing and toxic substances removing; Dissipating blood stasis for subsidence of swelling.Main furuncle toxic swelling; Tinea versicolor; Treating swelling and pain by traumatic injury; Venom.[extracts] " China's book on Chinese herbal medicine "
Herba Pelargonii Graveolentis: [another name] Artemisia argyi.[source] medical material Ji Yuan: be the stem and leaf of MangNiu Er Seedling section plant Pelargonium gravelens.Latin plant animal mineral name: Pelargonium graveolens L ' Herit.[nature and flavor] acrid in the mouth; Warm in nature.[return through] lung; Liver Channel.[function cures mainly] expelling wind and removing dampness; Promoting the circulation of QI to relieve pain; Parasite killing.Main air pain of dampness syndrome; Hernia; Eczema scrotum; Scabies.[extracts] " China's book on Chinese herbal medicine "
Caulis et Folium vitis viniferae: [another name] seedling of Fructus Vitis viniferae.[source] medical material Ji Yuan: be the rattan leaf of vitaceae Fructus Vitis viniferae.Latin plant animal mineral name: Vitis vinifera L.[nature and flavor] are sweet; Flat.[return through] kidney; Liver; Urinary bladder channel.[function cures mainly] expelling wind and removing dampness; Inducing diuresis to remove edema; Removing toxic substances.Main air pain of dampness syndrome; Edema; Diarrhoea; Wind heat conjunctival congestion; Carbuncle furuncle.[extracts] " China's book on Chinese herbal medicine "
Rhodobryum roseum Limpr.: [another name] great Ye moss, ferrum foot Rhizoma Arisaematis, Herba Polygoni Capitati.[source] medical material Ji Yuan: be the herb of the red great Ye moss of Bryaceae plant.Latin plant animal mineral name: Rhodobryum roseum (Hedw.) Limpr. [Mnium roseum Hedw.].[nature and flavor] are light; Micro-hardship; Flat.[return through] heart channel.[function cures mainly] tranquilizing by nourishing the heart; Calm.Main heart disease; Nervous; Severe palpitation; Neurasthenia.[extracts] " China's book on Chinese herbal medicine " " Chinese medicine voluminous dictionary "
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can be preferably: Herba Mimosae Pudicae 5 ~ 15 parts, Herba Centellae 10 ~ 20 parts, Folium Coicis 15 ~ 25 parts, Herba Allii bulleyani 10 ~ 20 parts, Rhizoma Polygoni coriacei 25 ~ 35 parts, Flos Celosiae Cristatae 22 ~ 32 parts, Caulis Cucurbitae 30 ~ 40 parts, Rhizoma Cynanchi Stauntonii 15 ~ 25 parts, Herba Eleusines Indicae 26 ~ 36 parts, Tremella mesenterica Retz ex Fr. 20 ~ 30 parts, Herba Goldffussiae Psilostachydis 8 ~ 18 parts, Herba Pelargonii Graveolentis 20 ~ 30 parts, Caulis et Folium vitis viniferae 16 ~ 26 parts and Rhodobryum roseum Limpr. 14 ~ 24 parts.
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can also be preferably: Herba Mimosae Pudicae 6 ~ 11 parts, Herba Centellae 15 ~ 20 parts, Folium Coicis 17 ~ 22 parts, Herba Allii bulleyani 12 ~ 17 parts, Rhizoma Polygoni coriacei 30 ~ 35 parts, Flos Celosiae Cristatae 24 ~ 29 parts, Caulis Cucurbitae 32 ~ 37 parts, Rhizoma Cynanchi Stauntonii 17 ~ 22 parts, Herba Eleusines Indicae 28 ~ 33 parts, Tremella mesenterica Retz ex Fr. 25 ~ 30 parts, Herba Goldffussiae Psilostachydis 11 ~ 16 parts, Herba Pelargonii Graveolentis 25 ~ 30 parts, Caulis et Folium vitis viniferae 19 ~ 24 parts and Rhodobryum roseum Limpr. 17 ~ 22 parts.
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can be preferably again: Herba Mimosae Pudicae 10 parts, Herba Centellae 16 parts, Folium Coicis 21 parts, Herba Allii bulleyani 13 parts, Rhizoma Polygoni coriacei 34 parts, Flos Celosiae Cristatae 25 parts, Caulis Cucurbitae 36 parts, Rhizoma Cynanchi Stauntonii 18 parts, Herba Eleusines Indicae 32 parts, Tremella mesenterica Retz ex Fr. 26 parts, Herba Goldffussiae Psilostachydis 15 parts, Herba Pelargonii Graveolentis 26 parts, Caulis et Folium vitis viniferae 20 parts and Rhodobryum roseum Limpr. 18 parts.
Wherein, in described Chinese medicine, the ratio of weight and number of each raw medicinal material can be preferably again: Herba Mimosae Pudicae 8 parts, Herba Centellae 18 parts, Folium Coicis 19 parts, Herba Allii bulleyani 15 parts, Rhizoma Polygoni coriacei 30 parts, Flos Celosiae Cristatae 28 parts, Caulis Cucurbitae 33 parts, Rhizoma Cynanchi Stauntonii 21 parts, Herba Eleusines Indicae 30 parts, Tremella mesenterica Retz ex Fr. 28 parts, Herba Goldffussiae Psilostachydis 12 parts, Herba Pelargonii Graveolentis 29 parts, Caulis et Folium vitis viniferae 22 parts and Rhodobryum roseum Limpr. 20 parts.
Wherein, when the dosage form of described Chinese medicine is tablet, its preparation method comprises the following steps:
The first step, is mixed in proportion each for described Chinese medicine raw medicinal material, and adding relative to the determining alcohol of mixture quality 2 ~ 4 times is the ethanol of 85 ~ 95%, reflux 1 ~ 3 hour, extracts, and filters acquisition first extracting solution; It is the ethanol of 85 ~ 95% that the medicinal residues that filtration obtains add relative to the determining alcohol of described medicinal residues quality 1 ~ 2 times again, reflux 1 ~ 3 hour, extracts, and filters acquisition second extracting solution; First extracting solution and the second extracting solution are merged, concentrating under reduced pressure removing alcohol solvent, dry, obtain and get dry extract;
Second step, is placed on the dry cream that the first step obtains in super micron mill and pulverizes 1 ~ 2 hour, pulverize, sieve, obtain 300 order ~ 400 object micropowders;
3rd step, by the micropowders that second step obtains, add relative to the microcrystalline Cellulose of its quality 0.1 ~ 0.3 times, 0.05 ~ 0.15 times of lactose, the starch of 0.1 ~ 0.3 times, sieve, mix homogeneously, granulate, drying, adds relative to micropowders quality 0.005 ~ 0.05 times of magnesium stearate, granulate, tabletting, makes.
Wherein, when the dosage form of described Chinese medicine is injectable powder, its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 0.1 ~ 10 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 3 ~ 5 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85% ~ 95%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 24 ~ 36 hours under the condition of 5 DEG C ~ 10 DEG C, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 40 ~ 60 minutes at this, the micron particles of acquisition 0.1 ~ 10 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets mixed powder 10g ~ 20g that second step obtains, adds propylene glycol 30g ~ 50g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1g ~ 1.5g needle-use activated carbon, fully stir 30 ~ 50 minutes; Decarbonization filtering; With 0.22 ~ 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
Below adopt embodiment to describe embodiments of the present invention in detail, to the present invention, how application technology means solve technical problem whereby, and the implementation procedure reaching technique effect can fully understand and implement according to this.
Embodiment 1: tablet
Get Herba Mimosae Pudicae 80g, Herba Centellae 180g, Folium Coicis 190g, Herba Allii bulleyani 150g, Rhizoma Polygoni coriacei 300g, Flos Celosiae Cristatae 280g, Caulis Cucurbitae 330g, Rhizoma Cynanchi Stauntonii 210g, Herba Eleusines Indicae 300g, Tremella mesenterica Retz ex Fr. 280g, Herba Goldffussiae Psilostachydis 120g, Herba Pelargonii Graveolentis 290g, Caulis et Folium vitis viniferae 220g and Rhodobryum roseum Limpr. 200g;
Its preparation method comprises the following steps:
The first step, is mixed in proportion each for described Chinese medicine raw medicinal material, and adding relative to the determining alcohol of mixture quality 3 times is the ethanol of 95%, reflux 2 hours, extracts, and filters acquisition first extracting solution; It is the ethanol of 95% that the medicinal residues that filtration obtains add relative to the determining alcohol of described medicinal residues quality 1 times again, reflux 2 hours, extracts, and filters acquisition second extracting solution; First extracting solution and the second extracting solution are merged, concentrating under reduced pressure removing alcohol solvent, dry, obtain and get dry extract;
Second step, is placed on the dry cream that the first step obtains in super micron mill and pulverizes 2 hours, pulverize, sieve, obtain 400 object micropowders;
3rd step, by the micropowders that second step obtains, adds relative to the microcrystalline Cellulose of its quality 0.2 times, 0.1 times of lactose, the starch of 0.2 times, sieves, mix homogeneously, granulates, dry, adds relative to micropowders quality 0.03 times of magnesium stearate, granulate, tabletting, makes.
Embodiment 2: injectable powder
Get Herba Mimosae Pudicae 100g, Herba Centellae 160g, Folium Coicis 210g, Herba Allii bulleyani 130g, Rhizoma Polygoni coriacei 340g, Flos Celosiae Cristatae 250g, Caulis Cucurbitae 360g, Rhizoma Cynanchi Stauntonii 180g, Herba Eleusines Indicae 320g, Tremella mesenterica Retz ex Fr. 260g, Herba Goldffussiae Psilostachydis 150g, Herba Pelargonii Graveolentis 260g, Caulis et Folium vitis viniferae 200g and Rhodobryum roseum Limpr. 180g;
Its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 4 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 4 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 28 hours under the condition of 7 DEG C, adopt percolation with the speed of 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 50 minutes at this, the micron particles of acquisition 2 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets the mixed powder 15g that second step obtains, adds propylene glycol 40g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1.35g needle-use activated carbon, fully stirs 30 minutes; Decarbonization filtering; With 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
Toxicity test:
Acute toxicity testing: application NIH mice 60, SPF level, male and female half and half, body weight 15 ~ 22g, carries out acute toxicity testing.Mice is divided into two groups at random, i.e. matched group and administration group, before experiment, fasting 12 hours, is dissolved in water by Chinese medicinal tablet prepared by embodiments of the invention 1, (concentration is 6.14g crude drug/ml, maximum concentration) gavage, gavage volume is 5ml/kg (namely unit dosage form is 30.7g crude drug/kg), and matched group gives normal saline, administration in 1 day 2 times, delivery time 6 hours, Continuous Observation 14 days after administration, and record toxic reaction and the death toll of mice.Experimental result shows: compare with matched group, and after administration, mice has no notable difference, experiment Continuous Observation 14 days, mouse systemic situation, ingest, drink water, body weight increases all normal.Mouse oral gavage tablet LD of the present invention
50> 30.7g crude drug/kg, every day, maximum dosage-feeding was 61.4g crude drug/kg/ day.Chinese medicine clinical application amount of the present invention in 6g crude drug/day/people, adult body weight in 60kg, average dosage is 0.1g crude drug/kg/ day.By weighing machine: the dosis tolerata of mice (average weight is in 18g) oral administration gavage Chinese medicine of the present invention is 614 times of quantity.Therefore Chinese medicine acute toxicity of the present invention is low, clinical drug safety.
Long term toxicity test: tablet prepared by the embodiment of the present invention 1 presses 8.27,19.38 and 36.47g crude drug/kg continuous use 16 weeks (1.0ml/100g body weight to mice, every day 2 times) and drug withdrawal after 4 weeks, result shows: the index such as hair, behavior, defecation, body weight, organ weights, hemogram, hepatic and renal function, blood glucose, blood fat of Chinese medicine of the present invention to rat all has no significant effect, internal organs naked eyes do not find that difference change and histological indications show, medication 16 weeks and drug withdrawal are after 4 weeks, and each internal organs of rat are all without obviously changing.Illustrate that Chinese medicine of the present invention is little to toxicity after rat long-term prescription, also there is no difference reaction after drug withdrawal, application safety.
Clinical data:
Case selection: fetch and come from my institute of in February, 2013 ~ in December, 2014 and be in hospital and the 126 routine iron Deficiency Anemia patients of outpatient, man 69 example, female 57 is routine; 6 months ~ 12 years old age; The anemia order of severity: slight 31 examples, moderate 73 example, severe 22 example.126 routine patients are divided into treatment by Chinese herbs group and western medicine group at random, treatment group 66 people, man 36 example, female 30 example; 6 months ~ 12 years old age; The anemia order of severity: slight 16 examples, moderate 38 example, severe 12 example.Matched group 60 people, man 33 example, female 27 example; 6 months ~ 12 years old age; The anemia order of severity: slight 15 examples, moderate 35 example, severe 10 example.
The anemia order of severity (hemoglobin standard) classification: slight: within being less than normal value 30g/L; Moderate: be less than normal value 31g/L ~ 60g/L; Severe: be less than normal value 61g/L ~ 90g/L.
Diagnostic criteria:
Western medicine diagnose standard: 1, anemia is the low color of minicell: (1) red cell morphology has the performance of obvious low pigment minicell, MCHC < 31%, MCV < 80FL, MCH < 27pg.(2) diagnostic criteria (in sea level) of anemia: blood of neonate Lactoferrin < 145g/L in raw latter 10 days, the standard that 10 days to 3 months babies affect anemia because of factors such as physiologic anemias is difficult to determine, suggestion temporarily with hemoglobin < 100g/L for anemia; 3 months to less than 6 years old < 110g/L, 6 ~ 14 years old < 120g/L.Height above sea level often increases 1000m, and hemoglobin raises about 4%.2, clear and definite Fe deficiency symptoms is had to increase or chronic blood loss etc. because of such as iron supply deficiency, malabsorption, needs.3, serum (slurry) ferrum < 10.7 μm of ol/L (60 μ g/d1).4, total iron binding capacity > 62.7 μm of ol/L (350 μ g/d1); Transferrin saturation < 15% has reference significance, and < 100% has exact meaning.5, the outer ferrum of medullary cell obviously reduces or disappear (0 ~+); Sideroblast < 15%.6, EP > 500 μ g/L.7, serum ferritin < 16 μ g/L.8, iron in treatment is effective.With iron in treatment after 6 weeks, hemoglobin more than rising 10g/L.Meet at least two articles of persons in the 1st article and 2 ~ 8 articles, diagnosable is iron deficiency anemia.
Syndrome Differentiation of Traditional Chinese Medicine standard: liver-kidney yin deficiency: dizziness and tinnitus, two dryness and uneasy feeling of the eye, Facial flush, burning pain in the hypochondrium, dysphoria with feverish sensation in the chest palms and soles, hectic fever night sweat, dry mouth and throat, or see wriggling of the limbs, red tongue with a little fluid, stringy,thready and rapid pulse.
Therapeutic Method:
Treatment by Chinese herbs group: take tablet prepared by the embodiment of the present invention 1, less than 3 years old, each 1, more than 3 years old each 2, every day 3 times, early, middle and late each once; Within 2 weeks, be 1 course for the treatment of, treat 3 courses for the treatment of.
Western medicine group: children's's ferrous sulfate syrup (contain logical Pharmaceutical, the accurate word H42022382 of traditional Chinese medicines), less than 1 years old, one time 1.5 milliliters, 3 times on the one; 1 ~ 5 year old, one time 3 milliliters, 3 times on the one; 6 ~ 12 years old, one time 8 milliliters, 2 times on the one; Within 2 weeks, be 1 course for the treatment of, treat 3 courses for the treatment of.
The standard of curative effect evaluation: draft with reference to " Chinese medical disease Standardization of diagnosis and curative effect ".Clinical cure: clinical symptoms and sign disappear, the lab testings such as chemical examination hemogram, serum levels of iron and iron-binding capacity are all normal.Effective: clinical symptoms and sign are obviously improved or substantially disappeared, lab testing such as chemical examination hemogram, serum levels of iron and iron-binding capacity etc. is clearly better or close to normal value.Invalid: clinical symptoms, sign and lab testing are all without improvement.
Therapeutic outcome: in table 1 and table 2.
Table 1 liang group treats Clinical efficacy comparison example (%) after 3 courses for the treatment of respectively
Group | Number of cases | Clinical cure | Effectively | Invalid | Total effective rate |
Treatment group | 66 | 56 | 8 | 2 | 64(97.0%) |
Matched group | 60 | 35 | 17 | 8 | 52(86.7%) |
As can be seen from Table 1, adopt Children Treated with Chinese Traditional Drugs iron deficiency anemia of the present invention, relative to Western medicine on therapeutic effect, there is significant improvement.
Table 2 liang group treats clinical cure number and time comparative example (%) after 3 courses for the treatment of respectively
Group | Number of cases | Treat 2 weeks | Treat 4 weeks | Treat 6 weeks |
Treatment group | 56 | 19(28.8%) | 47(71.2%) | 56(84.8%) |
Matched group | 35 | 6(10%) | 20(33.3%) | 35(58.3%) |
As can be seen from Table 2, adopt treatment by Chinese herbs iron deficiency anemia of the present invention, relative to Western medicine, treatment the course for the treatment of on significantly shorten, take effect faster.
According to the clinical statistics in above table, Chinese medicine provided by the invention have rapid-action, effective percentage is high, safety is high, the advantage that has no side effect.
Untoward reaction: treatment group 66 routine patient have no adverse reaction.The routine patient of matched group 60, nausea and vomiting 12 example, inappetence 16 example, upper abdomen distending pain 9 example, constipation 4 example, disappears in one week after general drug withdrawal.
Model case: Zhao, male, 5 years old, always say dizziness and tinnitus, face and trick heating, after being admitted to hospital, have a medical check-up, chemically examine and trace element test result: MIDA, TCM Syndrome Type: dizziness and tinnitus, two dryness and uneasy feeling of the eye, Facial flush, burning pain in the hypochondrium, dysphoria with feverish sensation in the chest palms and soles, hectic fever night sweat, dry mouth and throat, red tongue with a little fluid, stringy,thready and rapid pulse, further typing is liver-kidney yin deficiency iron Deficiency Anemia.Take tablet prepared by the embodiment of the present invention 1, every day 3 times, each 2, after taking medicine 2 weeks, all diseases disappear substantially; Continue to take medicine to 3 weeks, clinical symptoms and sign disappear completely, and the lab testings such as chemical examination hemogram, serum levels of iron and iron-binding capacity all recover normal, and woods Chu cures.Follow up a case by regular visits to half a year, do not recur.
The above is only preferred embodiment of the present invention, and be not restriction the present invention being made to other form, any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the Equivalent embodiments of equivalent variations.But everyly do not depart from technical solution of the present invention content, any simple modification, equivalent variations and the remodeling done above embodiment according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.
Claims (9)
1. treat a Chinese medicine for liver-kidney yin deficiency iron Deficiency Anemia, it is characterized in that, comprise following raw medicinal material: Herba Mimosae Pudicae, Herba Centellae, Folium Coicis, Herba Allii bulleyani, Rhizoma Polygoni coriacei, Flos Celosiae Cristatae, Caulis Cucurbitae, Rhizoma Cynanchi Stauntonii, Herba Eleusines Indicae, Tremella mesenterica Retz ex Fr., Herba Goldffussiae Psilostachydis, Herba Pelargonii Graveolentis, Caulis et Folium vitis viniferae and Rhodobryum roseum Limpr..
2. Chinese medicine as claimed in claim 1, it is characterized in that, in described Chinese medicine, the ratio of weight and number of each raw medicinal material is: Herba Mimosae Pudicae 5 ~ 15 parts, Herba Centellae 10 ~ 20 parts, Folium Coicis 15 ~ 25 parts, Herba Allii bulleyani 10 ~ 20 parts, Rhizoma Polygoni coriacei 25 ~ 35 parts, Flos Celosiae Cristatae 22 ~ 32 parts, Caulis Cucurbitae 30 ~ 40 parts, Rhizoma Cynanchi Stauntonii 15 ~ 25 parts, Herba Eleusines Indicae 26 ~ 36 parts, Tremella mesenterica Retz ex Fr. 20 ~ 30 parts, Herba Goldffussiae Psilostachydis 8 ~ 18 parts, Herba Pelargonii Graveolentis 20 ~ 30 parts, Caulis et Folium vitis viniferae 16 ~ 26 parts and Rhodobryum roseum Limpr. 14 ~ 24 parts.
3. Chinese medicine as claimed in claim 1 or 2, it is characterized in that, in described Chinese medicine, the ratio of weight and number of each raw medicinal material is: Herba Mimosae Pudicae 6 ~ 11 parts, Herba Centellae 15 ~ 20 parts, Folium Coicis 17 ~ 22 parts, Herba Allii bulleyani 12 ~ 17 parts, Rhizoma Polygoni coriacei 30 ~ 35 parts, Flos Celosiae Cristatae 24 ~ 29 parts, Caulis Cucurbitae 32 ~ 37 parts, Rhizoma Cynanchi Stauntonii 17 ~ 22 parts, Herba Eleusines Indicae 28 ~ 33 parts, Tremella mesenterica Retz ex Fr. 25 ~ 30 parts, Herba Goldffussiae Psilostachydis 11 ~ 16 parts, Herba Pelargonii Graveolentis 25 ~ 30 parts, Caulis et Folium vitis viniferae 19 ~ 24 parts and Rhodobryum roseum Limpr. 17 ~ 22 parts.
4. the Chinese medicine as described in claims 1 to 3, is characterized in that, in described Chinese medicine, the ratio of weight and number of each raw medicinal material is: Herba Mimosae Pudicae 10 parts, Herba Centellae 16 parts, Folium Coicis 21 parts, Herba Allii bulleyani 13 parts, Rhizoma Polygoni coriacei 34 parts, Flos Celosiae Cristatae 25 parts, Caulis Cucurbitae 36 parts, Rhizoma Cynanchi Stauntonii 18 parts, Herba Eleusines Indicae 32 parts, Tremella mesenterica Retz ex Fr. 26 parts, Herba Goldffussiae Psilostachydis 15 parts, Herba Pelargonii Graveolentis 26 parts, Caulis et Folium vitis viniferae 20 parts and Rhodobryum roseum Limpr. 18 parts.
5. the Chinese medicine as described in claims 1 to 3, is characterized in that, in described Chinese medicine, the ratio of weight and number of each raw medicinal material is: Herba Mimosae Pudicae 8 parts, Herba Centellae 18 parts, Folium Coicis 19 parts, Herba Allii bulleyani 15 parts, Rhizoma Polygoni coriacei 30 parts, Flos Celosiae Cristatae 28 parts, Caulis Cucurbitae 33 parts, Rhizoma Cynanchi Stauntonii 21 parts, Herba Eleusines Indicae 30 parts, Tremella mesenterica Retz ex Fr. 28 parts, Herba Goldffussiae Psilostachydis 12 parts, Herba Pelargonii Graveolentis 29 parts, Caulis et Folium vitis viniferae 22 parts and Rhodobryum roseum Limpr. 20 parts.
6. the Chinese medicine as described in claim 1 to 5, is characterized in that, the dosage form of described Chinese medicine is tablet, and its preparation method comprises the following steps:
The first step, is mixed in proportion each for described Chinese medicine raw medicinal material, and adding relative to the determining alcohol of mixture quality 2 ~ 4 times is the ethanol of 85 ~ 95%, reflux 1 ~ 3 hour, extracts, and filters acquisition first extracting solution; It is the ethanol of 85 ~ 95% that the medicinal residues that filtration obtains add relative to the determining alcohol of described medicinal residues quality 1 ~ 2 times again, reflux 1 ~ 3 hour, extracts, and filters acquisition second extracting solution; First extracting solution and the second extracting solution are merged, concentrating under reduced pressure removing alcohol solvent, dry, obtain and get dry extract;
Second step, is placed on the dry cream that the first step obtains in super micron mill and pulverizes 1 ~ 2 hour, pulverize, sieve, obtain 300 order ~ 400 object micropowders;
3rd step, by the micropowders that second step obtains, add relative to the microcrystalline Cellulose of its quality 0.1 ~ 0.3 times, 0.05 ~ 0.15 times of lactose, the starch of 0.1 ~ 0.3 times, sieve, mix homogeneously, granulate, drying, adds relative to micropowders quality 0.005 ~ 0.05 times of magnesium stearate, granulate, tabletting, makes.
7. the Chinese medicine as described in claim 1 to 5, is characterized in that, the dosage form of described Chinese medicine is injectable powder, and its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 0.1 ~ 10 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 3 ~ 5 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85% ~ 95%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 24 ~ 36 hours under the condition of 5 DEG C ~ 10 DEG C, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 40 ~ 60 minutes at this, the micron particles of acquisition 0.1 ~ 10 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets mixed powder 10g ~ 20g that second step obtains, adds propylene glycol 30g ~ 50g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1g ~ 1.5g needle-use activated carbon, fully stir 30 ~ 50 minutes; Decarbonization filtering; With 0.22 ~ 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
8. a preparation method for Chinese medicine described in claim 1 to 5, is characterized in that, the dosage form of described Chinese medicine is tablet, and its preparation method comprises the following steps:
The first step, is mixed in proportion each for described Chinese medicine raw medicinal material, and adding relative to the determining alcohol of mixture quality 2 ~ 4 times is the ethanol of 85 ~ 95%, reflux 1 ~ 3 hour, extracts, and filters acquisition first extracting solution; It is the ethanol of 85 ~ 95% that the medicinal residues that filtration obtains add relative to the determining alcohol of described medicinal residues quality 1 ~ 2 times again, reflux 1 ~ 3 hour, extracts, and filters acquisition second extracting solution; First extracting solution and the second extracting solution are merged, concentrating under reduced pressure removing alcohol solvent, dry, obtain and get dry extract;
Second step, is placed on the dry cream that the first step obtains in super micron mill and pulverizes 1 ~ 2 hour, pulverize, sieve, obtain 300 order ~ 400 object micropowders;
3rd step, by the micropowders that second step obtains, add relative to the microcrystalline Cellulose of its quality 0.1 ~ 0.3 times, 0.05 ~ 0.15 times of lactose, the starch of 0.1 ~ 0.3 times, sieve, mix homogeneously, granulate, drying, adds relative to micropowders quality 0.005 ~ 0.05 times of magnesium stearate, granulate, tabletting, makes.
9. a preparation method for Chinese medicine described in claim 1 to 5, is characterized in that, the dosage form of described Chinese medicine is injectable powder, and its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 0.1 ~ 10 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 3 ~ 5 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85% ~ 95%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 24 ~ 36 hours under the condition of 5 DEG C ~ 10 DEG C, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 40 ~ 60 minutes at this, the micron particles of acquisition 0.1 ~ 10 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets mixed powder 10g ~ 20g that second step obtains, adds propylene glycol 30g ~ 50g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1g ~ 1.5g needle-use activated carbon, fully stir 30 ~ 50 minutes; Decarbonization filtering; With 0.22 ~ 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510413255.5A CN104984164A (en) | 2015-07-14 | 2015-07-14 | Traditional Chinese medicine for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia and preparing method of traditional Chinese medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510413255.5A CN104984164A (en) | 2015-07-14 | 2015-07-14 | Traditional Chinese medicine for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia and preparing method of traditional Chinese medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104984164A true CN104984164A (en) | 2015-10-21 |
Family
ID=54296143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510413255.5A Pending CN104984164A (en) | 2015-07-14 | 2015-07-14 | Traditional Chinese medicine for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia and preparing method of traditional Chinese medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104984164A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147570A (en) * | 2014-08-17 | 2014-11-19 | 范征美 | Traditional Chinese medicine preparation for treating children with iron deficiency anemia |
CN104208098A (en) * | 2013-05-31 | 2014-12-17 | 孙冰清 | Chinese medicine for treating children iron-deficiency anemia |
-
2015
- 2015-07-14 CN CN201510413255.5A patent/CN104984164A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104208098A (en) * | 2013-05-31 | 2014-12-17 | 孙冰清 | Chinese medicine for treating children iron-deficiency anemia |
CN104147570A (en) * | 2014-08-17 | 2014-11-19 | 范征美 | Traditional Chinese medicine preparation for treating children with iron deficiency anemia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933A (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
CN104397431A (en) | Compound feeds for treating bovine urolithiasis and preparation method for compound feeds | |
CN104799115A (en) | Chicken compound feed and preparation method thereof | |
CN103690919A (en) | Medicine for treating piglet iron-deficiency anemia and preparation method of medicine | |
CN103933509B (en) | For treating medicine of fresh-water fishes fish molds and preparation method thereof | |
CN102078569B (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof | |
CN104721672A (en) | Traditional Chinese medicine preparation for treating adhesive intestinal obstruction and preparation method thereof | |
CN103463449A (en) | Traditional Chinese medicine composite used for treating haemorrhoids and preparation method and application thereof | |
CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
CN104547902A (en) | Application of traditional Chinese preparation in preparation of drugs used for treating chronic enteritis and appendicitis | |
CN104547798A (en) | Traditional Chinese medicine preparation for treating chronic enteritis and appendicitis and preparation method thereof | |
CN104721629B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of iron Deficiency Anemia | |
CN103893737A (en) | Medicament used for treating bronchial asthma and preparation method thereof | |
CN105147956A (en) | Traditional Chinese medicine for treating acute peptic ulcer bleeding and preparation method of traditional Chinese medicine | |
CN104984164A (en) | Traditional Chinese medicine for treating liver-yin and kidney-yin deficiency type pediatric iron-deficiency anemia and preparing method of traditional Chinese medicine | |
CN104815217A (en) | Pharmaceutical composition for treating pigeon body psoroptic mange and preparation method of pharmaceutical composition | |
CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
CN103432416B (en) | Chinese herba preparation for treating children iron-deficiency anemia and preparation method thereof | |
CN105560984B (en) | Traditional Chinese medicine composition capable of boosting qi and invigorating spleen | |
CN103690771B (en) | Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof | |
CN104491709A (en) | Pharmaceutical composition for treating bovine lithangiuria and preparation method of pharmaceutical composition | |
CN104206597B (en) | A kind of schisandra health care tea alleviating YIN-deficiency of the lung and kidney symptom and preparation method thereof | |
CN105535895B (en) | Traditional Chinese medicine composition for treating productive coughs | |
CN104383387A (en) | Traditional Chinese medicine preparation for treating canine viral hepatitis and preparation method thereof | |
CN104623563A (en) | Traditional-Chinese-medicine preparation for postoperative rehabilitation of sigmoid colon cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151021 |